KR20190143032A - A Pharmaceutical composition used for medical-treatment and health-care hat - Google Patents
A Pharmaceutical composition used for medical-treatment and health-care hat Download PDFInfo
- Publication number
- KR20190143032A KR20190143032A KR1020180070476A KR20180070476A KR20190143032A KR 20190143032 A KR20190143032 A KR 20190143032A KR 1020180070476 A KR1020180070476 A KR 1020180070476A KR 20180070476 A KR20180070476 A KR 20180070476A KR 20190143032 A KR20190143032 A KR 20190143032A
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- parts
- pharmaceutical composition
- health care
- medical treatment
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 41
- 238000011282 treatment Methods 0.000 title claims abstract description 27
- 239000004677 Nylon Substances 0.000 claims description 15
- 229920001778 nylon Polymers 0.000 claims description 15
- 241000125175 Angelica Species 0.000 claims description 14
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 14
- 150000003839 salts Chemical class 0.000 claims description 11
- 241001061264 Astragalus Species 0.000 claims description 8
- 235000006533 astragalus Nutrition 0.000 claims description 8
- 210000004233 talus Anatomy 0.000 claims description 8
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 6
- 229910052802 copper Inorganic materials 0.000 claims description 6
- 239000010949 copper Substances 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 230000002087 whitening effect Effects 0.000 claims description 6
- 238000005303 weighing Methods 0.000 claims description 4
- 239000011162 core material Substances 0.000 claims description 3
- 238000000227 grinding Methods 0.000 claims description 3
- 239000004615 ingredient Substances 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 239000002245 particle Substances 0.000 claims description 3
- 238000007873 sieving Methods 0.000 claims description 3
- 239000013078 crystal Substances 0.000 claims description 2
- 238000000034 method Methods 0.000 claims description 2
- 238000010298 pulverizing process Methods 0.000 claims description 2
- 238000007789 sealing Methods 0.000 claims description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 abstract description 4
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract description 4
- 229940116229 borneol Drugs 0.000 abstract description 4
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract description 4
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract description 4
- 241000382455 Angelica sinensis Species 0.000 abstract description 2
- 239000009636 Huang Qi Substances 0.000 abstract description 2
- 241000691155 Pteris multifida Species 0.000 abstract description 2
- 241000270273 Ptyas dhumnades Species 0.000 abstract description 2
- 244000291333 Serissa japonica Species 0.000 abstract description 2
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 abstract description 2
- 229910052602 gypsum Inorganic materials 0.000 abstract description 2
- 239000010440 gypsum Substances 0.000 abstract description 2
- 230000000694 effects Effects 0.000 description 10
- 239000003814 drug Substances 0.000 description 7
- 206010019233 Headaches Diseases 0.000 description 4
- 241000736199 Paeonia Species 0.000 description 4
- 235000006484 Paeonia officinalis Nutrition 0.000 description 4
- 238000001467 acupuncture Methods 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 231100000869 headache Toxicity 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 208000012902 Nervous system disease Diseases 0.000 description 2
- 208000025966 Neurological disease Diseases 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 208000032625 disorder of ear Diseases 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 208000030533 eye disease Diseases 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 238000002653 magnetic therapy Methods 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 208000000044 Amnesia Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 201000006474 Brain Ischemia Diseases 0.000 description 1
- 206010008120 Cerebral ischaemia Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 241000219130 Cucurbita pepo subsp. pepo Species 0.000 description 1
- 235000003954 Cucurbita pepo var melopepo Nutrition 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000026139 Memory disease Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000000133 brain stem Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 210000001736 capillary Anatomy 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000006984 memory degeneration Effects 0.000 description 1
- 208000023060 memory loss Diseases 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 229940124595 oriental medicine Drugs 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 210000000578 peripheral nerve Anatomy 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000006442 vascular tone Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/583—Snakes; Lizards, e.g. chameleons
-
- A—HUMAN NECESSITIES
- A42—HEADWEAR
- A42B—HATS; HEAD COVERINGS
- A42B1/00—Hats; Caps; Hoods
-
- A—HUMAN NECESSITIES
- A42—HEADWEAR
- A42B—HATS; HEAD COVERINGS
- A42B1/00—Hats; Caps; Hoods
- A42B1/017—Hats; Caps; Hoods specially adapted for promoting health, e.g. with means for pressing on acupuncture points
- A42B1/0175—Hats; Caps; Hoods specially adapted for promoting health, e.g. with means for pressing on acupuncture points using magnets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/882—Acoraceae (Calamus family), e.g. sweetflag or Acorus calamus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8988—Gastrodia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Pain & Pain Management (AREA)
- Medicines Containing Plant Substances (AREA)
- Magnetic Treatment Devices (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
본 발명은 건강 관리 의약 분야에 관련한 의학적 치료 및 건강 관리 모자에 사용되는 약학적 조성물에 관한 것이다.The present invention relates to pharmaceutical compositions for use in medical treatments and health care hats in the field of healthcare medicine.
다양한 뇌와 신경계의 비유기적 장애들은 종종 사람들의 두통과 어지러움에 이르게 하지만, 다양한 탐지를 통해도 의미있는 병리학적 질병들이 입증되지는 않는다. 그러나, 이러한 증상들은 사람들의 일과 삶에 심각한 영향을 미치기 때문에 극복해야 한다. 현재, 그것들을 조절할 수 있는 효과적인 약이 없다. 게다가, 몇 경구용 의약이 효과적일지라도, 그들의 부작용이 심각하다. 중국 특허 공보에 게재된 건강 관리 모자(CN2050264U), 건강 안전 헬멧(CN2130369Y) 및 눈과 귀 질병들 치료를 위한 의학 모자(CN1065003A) 3가지 특허 출원은 모두 "경혈 드레싱" 요법의 적용에 기반한 것이고, 어떤 투약 형태로 제조되고 모자 내부에 위치할 수 있는 적절한 한약제제를 선택하는 것으로 특징되어지며, 건강관리 목적 달성을 위해 사람 머리의 경혈에 씌워지는 것들이다. 처음 두 개의 특허 출원은 실용 신안 특허 출원에 속하고, 그것들의 한약제제들은 공개되지 않으며, 중국 특허법에 의해 보호받지 못하고, 예방되고 치료될 수 있는 질병들의 관점에서 제한이 있는 반면, 세번째 특허 출원에서 공개된 약학적 모자는 눈과 귀의 질병 치료에 전용으로 사용되고, 다른 질병들의 치료에 사용될 수 없다.The various organic disorders of the brain and nervous system often lead to headaches and dizziness in people, but various pathologies do not prove significant pathological diseases. However, these symptoms have to be overcome because they severely affect people's work and lives. At present, there are no effective medicines to control them. In addition, although some oral medications are effective, their side effects are serious. The three patent applications of the Health Care Hat (CN2050264U), Health Safety Helmet (CN2130369Y) and Medical Hat for the Treatment of Eye and Ear Diseases (CN1065003A) published in the Chinese Patent Publication are all based on the application of "acupoint dressing" therapy, It is characterized by the selection of an appropriate herbal preparation that can be made in any dosage form and placed inside the cap, and is placed on the acupuncture points on the human head to achieve health care purposes. The first two patent applications belong to the utility model patent application, their herbal preparations are not published, and are not protected by Chinese patent law and have limitations in terms of diseases that can be prevented and treated, while in the third patent application The disclosed pharmaceutical caps are used exclusively for the treatment of eye and ear diseases and cannot be used for the treatment of other diseases.
본 발명의 목적은 바람직한 약제를 선택한 의학적 치료 및 건강 관리 모자에 사용되는 약학적 조성물을 제공하는 것이고, 사람에게 가장 흔한 심혈관 질환 및 신경 질환의 예방과 치료가 가능하며, 더 편리한 사용법, 더 높은 안전성 및 더 나은 효과를 갖는 것에 있다.It is an object of the present invention to provide a pharmaceutical composition for use in medical treatments and health care caps with the selection of preferred agents, which enables the prevention and treatment of the most common cardiovascular and neurological diseases in humans, more convenient in use, higher safety And having a better effect.
1. 의학적 치료 및 건강 관리 모자에 사용되는 약학적 조성물로서,1.A pharmaceutical composition used in medical treatment and health care caps,
사담 3 내지 10 중량부, 봉미초 4 내지 12 중량부, 백정화 4 내지 10 중량부, 적작약 4 내지 10 중량부, 황기 5 내지 10 중량부, 당귀 5 내지 12 중량부, 천마 5 내지 12 중량부 및 석창포 5 내지 10 중량부를 포함하는 약학적 조성물. 3 to 10 parts by weight of Saddam, 4 to 12 parts by weight of Bongmicho, 4 to 10 parts by weight of white crystals, 4 to 10 parts by weight of zucchini, 5 to 10 parts by weight of Astragalus, 5 to 12 parts by weight, Angelica 5 to 12 parts by weight, and Pharmaceutical composition comprising 5 to 10 parts by weight of Seokchangpo.
2. 위 1에 따른 의학적 치료 및 건강 관리 모자에 사용되는 약학적 조성물에 있어서, 보르네올 1 내지 2 중량부를 더 포함하는 약학적 조성물.2. The pharmaceutical composition used in the medical treatment and health care cap according to the above 1, further comprising 1 to 2 parts by weight of borneool.
3. 위 1 또는 2에 따른 의학적 치료 및 건강 관리 모자에 사용되는 약학적 조성물에 있어서, 염정 10 내지 20 중량부를 더 포함하는 약학적 조성물.3. The pharmaceutical composition used in the medical treatment and health care cap according to the above 1 or 2, wherein the pharmaceutical composition further comprises 10 to 20 parts by weight of the salt.
4. 위 1 또는 2에 따른 의학적 치료 및 건강 관리 모자에 사용되는 약학적 조성물에 있어서, 자석 20 내지 25 중량부를 더 포함하는 약학적 조성물.4. The pharmaceutical composition used in the medical treatment and health care cap according to the above 1 or 2, wherein the pharmaceutical composition further comprises 20 to 25 parts by weight of a magnet.
5. 위 3에 따른 의학적 치료 및 건강 관리 모자에 사용되는 약학적 조성물에 있어서, 자석 20 내지 25 중량부를 더 포함하는 약학적 조성물.5. The pharmaceutical composition used in the medical treatment and health care cap according to the above 3, wherein the pharmaceutical composition further comprises 20 to 25 parts by weight of a magnet.
6. 위 1 내지 5 중 어느 하나에 따른 약학적 조성물이 속에 배치된 모자.6. The cap disposed in the pharmaceutical composition according to any one of the above 1 to 5.
7. a. 황기와 천마를 일정량 취한 후, 수분 함량이 5% 미만이 될 때까지 80℃의 건조기에서 2시간 동안 건조하고 분쇄한 후, 40 메쉬의 나일론 체로 거르는 단계;7. a. After taking a certain amount of Astragalus and Cheonmas, drying and grinding for 2 hours in a dryer at 80 ℃ until the moisture content is less than 5%, and then sieving with a 40 mesh nylon sieve;
b. 사담, 봉미초, 석창포 각각을 일정량 취하고, 체관부와 심재를 제거한 후 물로 씻어내며, 약 3mm의 두께의 작은 조각으로 잘라내고, 하루동안 햇볕에 건조시키고, 수분 ?량이 5% 미만이 될 때까지 60℃의 건조기에서 3시간 동안 건조한 후 꺼내어 상온에서 식히고, 분쇄하며, 40 메쉬의 나일론 체로 거르는 단계;b. Take a certain amount of Saddam, Bongmicho and Seokchangpo each, remove the phloem and core material, wash with water, cut into small pieces of about 3mm thick, dry in the sun for one day, until the moisture content is less than 5%. Drying in a dryer at 3 ° C. for 3 hours, taken out, cooled to room temperature, ground, and sieved through a 40 mesh nylon sieve;
c. 백정화를 일정량 취하고, 백정화의 1/4 양의 황색 포도주를 백정화에 첨가하며, 균일하게 혼합하고, 커버로 1시간 동안 밀봉한 후, 색이 갈색이 되고 수분 함량이 5% 미만이 될 때까지 약한 불의 구리 팬에 볶고, 꺼내어 상온에서 식힌 후 분쇄하며, 40 메쉬 나일론 체로 거르는 단계;c. Take a certain amount of whitening, add a quarter of yellow wine to the whitening, mix uniformly, seal with cover for 1 hour, and then weaken until the color becomes brown and the moisture content is less than 5% Roasting in a copper pan of fire, taken out, cooled to room temperature, and then pulverized and filtered with a 40 mesh nylon sieve;
d. 당귀를 일정량 취하고, 당귀의 1/10 양의 황색 포도주를 당귀에 첨가하며, 균일하게 혼합하고, 커버로 1시간 동안 밀봉한 후, 색이 진한 갈색이 되고 수분 함량이 5% 미만이 될 때까지 약한 불의 구리 팬에 볶고, 꺼내어 상온에서 식힌 후 분쇄하며, 40 메쉬 나일론 체로 거르는 단계;d. Take a certain amount of Angelica, add 1/10 of the yellow wine of Angelica to Angelica, mix evenly, seal with cover for 1 hour, until dark brown and less than 5% moisture content Roasting in a low heat copper pan, taken out, cooled to room temperature and then ground and sieved through a 40 mesh nylon sieve;
e. 적작약과 염정 각각을 일정량 취하고, 4시간 동안 60℃의 오븐에서 건조한 후, 꺼내어 적작약(염정은 제외)의 수분 함량이 5% 미만이 되도록 상온에서 식힌 다음, 각각 분쇄하고 40 메쉬 나일론 체로 거르는 단계;e. Taking a predetermined amount of each of the dropping peony and the salt, dried in an oven at 60 ° C. for 4 hours, then taken out and cooled at room temperature so that the water content of the dropping peony (excluding the salt) is less than 5%, followed by crushing and filtering with a 40 mesh nylon sieve;
f. 일정량의 자석을 계량하고, 평균 직경이 0.5mm의 작은 자석 입자로 제조하는 단계;f. Weighing a certain amount of magnet and preparing the small magnet particles with an average diameter of 0.5 mm;
g. 상기 각 약학적 성분들 적당량을 계량하고 혼합하며, 균등하게 분쇄한 후 밀봉하는 단계; g. Measuring and mixing an appropriate amount of each of the pharmaceutical ingredients, evenly pulverizing and sealing;
를 포함하는 의학적 치료 및 건강 관리 모자에 사용되는 약학적 조성물의 제조방법.Method of producing a pharmaceutical composition used for medical treatment and health care cap comprising a.
본 발명은 바람직한 약제를 선택한 의학적 치료 및 건강 관리 모자에 사용되는 약학적 조성물을 제공하여, 사람에게 가장 흔한 심혈관 질환 및 신경 질환의 예방과 치료가 가능하며, 더 편리한 사용법, 더 높은 안전성 및 더 나은 효과를 제공한다.The present invention provides a pharmaceutical composition for use in medical treatments and health care caps selected for the preferred agent, enabling the prevention and treatment of the most common cardiovascular and neurological diseases in humans, with more convenient usage, higher safety and better Provide effect.
본 발명의 의학적 치료 및 건강 관리 모자에 사용되는 약학적 조성물은 사담(Zaocys dhumnade) 3 내지 10 중량부, 봉미초(Chinese Brake Herb) 4 내지 12 중량부, 백정화(Serissa serissoide) 4 내지 10 중량부, 적작약(Radix Paeoniae Rubra) 4 내지 10 중량부, 황기(Radix Astragali) 5 내지 10 중량부, 당귀(Angelica sinensis) 5 내지 12 중량부, 천마(Rhizoma Gastrodiae) 5 내지 12 중량부, 석창포(Rhizoma Acori Graminei) 5 내지 10 중량부를 포함한다.The pharmaceutical composition used in the medical treatment and health care cap of the present invention is 3 to 10 parts by weight of Zaocys dhumnade, 4 to 12 parts by weight of Chinese Brake Herb, 4 to 10 parts by weight of Serissa serissoide , 4-10 parts by weight of Radix 작 Paeoniae Rubra, 5-10 parts by weight of Radix Astragali, 5-12 parts by weight of Angelica sinensis, 5-12 parts by weight of Rhizoma Gastrodiae, Rhizoma Acori Graminei) 5 to 10 parts by weight.
본 발명의 의학적 치료 및 건강 관리 모자에 사용되는 약학적 조성물은, 울화(stagnated fire)를 소거하고 소생(resuscitation)을 유도하는 효과가 있는 보르네올(borneol) 1 내지 2 중량부를 더 포함할 수 있다.The pharmaceutical composition used in the medical treatment and health care cap of the present invention may further include 1 to 2 parts by weight of borneol having an effect of eliminating stagnated fire and inducing rescitation. .
본 발명의 의학적 치료 및 건강 관리 모자에 사용되는 약학적 조성물은, 심화(heart-fire)를 제거하고 상기 약제들의 자극적-온화한 속성(pungent-warm properties)을 억제시켜주는 염정(gypsum rubrum) 10 내지 20 중량부를 더 포함할 수 있고, 이는 약제의 활성성분에 대한 흡수 효과를 가지고, 약제의 서방 효과를 제공할 수 있다.The pharmaceutical compositions used in the medical treatment and health care caps of the present invention may be characterized by the use of gypsum rubrum 10 to remove the heart-fire and to suppress the pungent-warm properties of the drugs. It may further comprise 20 parts by weight, which has an absorption effect on the active ingredient of the medicament, may provide a sustained release effect of the medicament.
본 발명의 의학적 치료 및 건강 관리 모자에 사용되는 약학적 조성물은, 자석 요법에의 주요한 역할을 하고 상기 약제들과 시너지 효과를 내는 자석(magnetitum) 20 내지 25 중량부를 더 포함할 수 있다. The pharmaceutical composition used in the medical treatment and health care cap of the present invention may further comprise 20 to 25 parts by weight of a magnet (magnetitum), which plays a major role in magnet therapy and synergizes with the drugs.
본 발명은 하기의 장점과 효과를 갖는다: (1) 작용 부위는 유일하고, 작용 부위는 주로 사람의 머리 상단의 백회(Baihui acupoint)의 경혈 주변에 위치하고 있다. 일관된 현대 생리학의 설명에 따를 때, 인간의 뇌는 중추 신경계의 가장 높은 본부이고, 내장, 팔다리 및 뼈를 담당한다. 이는 머리가 인간의 신체에 있어 중요하다는 사실을 나타낸다. 게다가, 고대의 건강관리인(health-maintenance people), 도교 성직자들 및 불교 성지 사람들은 이 경혈점에 대해 특별한 관심을 보이고, 이 경혈점이 상부의 치골부위(upper pubic region)가 위치한 곳이라고 믿는다. 현대 의학은 또한 입증했다: 머리 속의 뇌에 본질적으로 연결된 매우 풍부한 모세 혈관과 말초 신경들이 존재하고, 머리는 단위체 표면적이 대부분의 열을 방출하는 장소이며, 이는 휘발을 촉진하고 약학적 조성물의 휘발성 활성 성분을 흡수하는데 매우 유리하다. (2) 그것은 사용이 매우 쉽고, 정상 근무, 공부 및 휴식에 영향 없이 그것은 단지 머리에 모자를 쓰기만 하면 되며, 모자의 최상부를 머리의 최상부의 중심에 위치한 백회의 경혈 부위에 접촉시키도록 하면 된다. 모자는 실용적이고 장식적이며, 심지어 여성들의 현대 여성들의 헤어 관리에 필수적인 도구이기도 하다; 그것은 무게가 가볍고, 사이즈가 작으며, 저장하고 휴대하기 용이하다. 본 약학적 조성물은 향기가 나고 독성이나 부작용이 없으며, 정확한 치료효과와 긴 서비스 수명을 가지고, 안전하고 신뢰할 수 있으며, 피부에 자극을 주지 않는다. (3) 본 발명의 약학적 조성물은 신양(kidney-yang)의 보충, 혈액순환의 촉진, 울화의 소거, 소생 유도, 진정시킴 및 흥분 가라앉힘, 열의 제거 및 안절부절 못함의 감소, 기(Qi)의 순환 촉진 및 고통 완화, 혈액 정체 제거를 위한 혈액 순환 촉진 및 발작과 경련의 완화 기능이 있다. 본 약학적 조성물은 고혈압, 관상 동맥 심장 질환, 협심증, 혈관 긴장성 두통, 삼차 신경성 두통, 외인성 두통, 어지럼증, 이명 및 기억력 상실 등에 대한 현저한 치료효과 및 건강관리 효과가 있고; 심장 허혈 및 대뇌 허혈을 완화할 수 있으며, 효과적으로 죽상동맥경화증의 발생을 예방하기 위하여 혈액순환과 혈관 내벽 퇴적물의 용해를 촉진한다. 본 발명은 매우 향상된 치료효과를 달성하기 위해, 경혈 드레싱 요법 및 자석 요법 한의학과 시너지를 이룰 수 있다.The present invention has the following advantages and effects: (1) The site of action is unique, and the site of action is mainly located around the acupuncture points of Baihui acupoint at the top of the human head. According to the consistent description of modern physiology, the human brain is the highest head of the central nervous system and is responsible for the intestines, limbs and bones. This indicates that the head is important for the human body. In addition, ancient health-maintenance people, Taoist clergy, and Buddhist sanctuaries pay special attention to this acupoint, and believe that it is where the upper pubic region is located. Modern medicine has also demonstrated: there are very rich capillaries and peripheral nerves that are intrinsically connected to the brain in the head, and the head is the place where the unit surface area releases most of the heat, which promotes volatilization and volatile activity of the pharmaceutical composition. It is very advantageous to absorb the components. (2) It is very easy to use, and without affecting normal work, study and rest it is only necessary to wear a hat on the head and to contact the top of the hat with the white acupuncture points in the center of the head . Hats are practical and decorative and are even an essential tool for hair care of modern women, even women; It is light in weight, small in size and easy to store and carry. The pharmaceutical composition is fragrant, has no toxicity or side effects, has an accurate therapeutic effect and a long service life, is safe and reliable, and does not irritate the skin. (3) The pharmaceutical composition of the present invention is supplemented with (kidney-yang), promoting blood circulation, eliminating fever, inducing resuscitation, calming and excitement, elimination of heat and reduction of restlessness, Qi To promote circulation and relieve pain, to promote blood circulation to eliminate blood congestion, and to relieve seizures and cramps. The pharmaceutical composition has a significant therapeutic effect and health care effect against hypertension, coronary heart disease, angina pectoris, vascular tone headache, trigeminal neuron headache, exogenous headache, dizziness, tinnitus and memory loss; It can alleviate cardiac ischemia and cerebral ischemia, and promote blood circulation and dissolution of vascular inner wall deposits effectively to prevent the development of atherosclerosis. The present invention can achieve synergy with acupuncture point dressing therapy and magnet therapy oriental medicine to achieve a very improved therapeutic effect.
이하, 실시예들과 함께 본 발명을 구체적으로 설명한다.Hereinafter, the present invention will be described in detail with examples.
실시예Example 1 One
본 발명의 약학적 조성물은 사담 3g, 봉미초 4g, 백정화 4g, 적작약 5g, 황기 5g, 당귀 5g, 천마 5g, 석창포 5g, 보르네올 1g, 염정 10g 및 자석 20g(600 가우스)을 포함한다.The pharmaceutical composition of the present invention includes 3 g of Saddam, 4 g of Bongmicho, 4 g of Bakhwajeong, 5 g of Red Drop, 5 g of Astragalus, 5 g of Angelica, 5 g of Cheonma, 5 g of Seokchangpo, 1 g of Borneol, 10 g of salt, and 20 g of a magnet (600 gauss).
실시예Example 2 2
본 발명의 약학적 조성물은 사담 10g, 봉미초 12g, 백정화 12g, 적작약 10g, 황기 10g, 당귀 12g, 석창포 10g, 염정 20g 및 자석 25g(700 가우스)을 포함한다.The pharmaceutical composition of the present invention includes 10 g of Saddam, 12 g of Bongmicho, 12 g of Bakhwacho, 10 g of Red Drop, 10 g of Astragalus, Angelica 12 g, 10 g of Seokchangpo, 20 g of salt, and 25 g of a magnet (700 gauss).
실시예Example 3 3
본 발명의 약학적 조성물은 사담 8g, 봉미초 8g, 백정화 7g, 적작약 7g, 황기 8g, 당귀 9g, 천마 9g, 석창포 6g, 보르네올 2g, 염정 15g 및 자석 23g(800 가우스)을 포함한다.The pharmaceutical composition of the present invention includes 8 g of Saddam, 8 g of Bongmicho, 7 g of Bakhwajeong, 7 g of Red Drop, 8 g of Astragalus, 9 g of Angelica, 9 g of Cheonma, 6 g of Stone Changpo, 2 g of Borneol, 15 g of Salt, and 23 g of Magnet (800 Gauss).
다음으로, 본 발명 약학적 조성물의 제조방법을 설명한다:Next, the preparation method of the pharmaceutical composition of the present invention will be described:
a. 황기와 천마를 일정량 취한 후, 수분 함량이 5% 미만이 될 때까지 80℃의 건조기에서 2시간 동안 건조하고 분쇄한 후, 40 메쉬의 나일론 체로 거르는 단계;a. After taking a certain amount of Astragalus and Cheonmas, drying and grinding for 2 hours in a dryer at 80 ℃ until the moisture content is less than 5%, and then sieving with a 40 mesh nylon sieve;
b. 사담, 봉미초, 석창포 각각을 일정량 취하고, 체관부와 심재를 제거한 후 물로 씻어내며, 약 3mm의 두께의 작은 조각으로 잘라내고, 하루동안 햇볕에 건조시키고, 수분 ?량이 5% 미만이 될 때까지 60℃의 건조기에서 3시간 동안 건조한 후 꺼내어 상온에서 식히고, 분쇄하며, 40 메쉬의 나일론 체로 거르는 단계;b. Take a certain amount of Saddam, Bongmicho and Seokchangpo each, remove the phloem and core material, wash with water, cut into small pieces of about 3mm thick, dry in the sun for one day, until the moisture content is less than 5%. Drying in a dryer at 3 ° C. for 3 hours, taken out, cooled to room temperature, ground, and sieved through a 40 mesh nylon sieve;
c. 백정화를 일정량 취하고, 백정화의 1/4 양의 황색 포도주를 백정화에 첨가하며, 균일하게 혼합하고, 커버로 1시간동안 밀봉한 후, 색이 갈색이 되고 수분 함량이 5% 미만이 될 때까지 약한 불의 구리 팬에 볶고, 꺼내어 상온에서 식힌 후 분쇄하며, 40 메쉬 나일론 체로 거르는 단계;c. Take a certain amount of whitening, add a quarter of yellow wine to the whitening, mix evenly, seal with cover for 1 hour, and then weaken until the color becomes brown and the moisture content is less than 5%. Roasting in a copper pan of fire, taken out, cooled to room temperature, and then pulverized and filtered with a 40 mesh nylon sieve;
d. 당귀를 일정량 취하고, 당귀의 1/10 양의 황색 포도주를 당귀에 첨가하며, 균일하게 혼합하고, 커버로 1시간동안 밀봉한 후, 색이 진한 갈색이 되고 수분 함량이 5% 미만이 될 때까지 약한 불의 구리 팬에 볶고, 꺼내어 상온에서 식힌 후 분쇄하며, 40 메쉬 나일론 체로 거르는 단계;d. Take a certain amount of Angelica, add 1/10 of yellow wine of Angelica to Angelica, mix evenly, seal with cover for 1 hour, until dark brown and less than 5% moisture content Roasting in a low heat copper pan, taken out, cooled to room temperature and then ground and sieved through a 40 mesh nylon sieve;
e. 적작약과 염정 각각을 일정량 취하고, 4시간 동안 60℃의 오븐에서 건조한 후, 꺼내어 적작약(염정은 제외)의 수분 함량이 5% 미만이 되도록 상온에서 식힌 다음, 각각 분쇄하고 40 메쉬 나일론 체로 거르는 단계;e. Taking a predetermined amount of each of the dropping peony and the salt, dried in an oven at 60 ° C. for 4 hours, then taken out and cooled at room temperature so that the water content of the dropping peony (excluding the salt) is less than 5%, followed by crushing and filtering with a 40 mesh nylon sieve;
f. 일정량의 자석을 계량하고, 평균 직경이 0.5mm의 작은 자석 입자로 제조하는 단계;f. Weighing a certain amount of magnet and preparing the small magnet particles with an average diameter of 0.5 mm;
g. 상기 각 약학적 성분들 적당량을 계량하고 혼합하며, 균등하게 분쇄한 후 밀봉하는 단계.g. Weighing and mixing the appropriate amount of each of the pharmaceutical ingredients, evenly milled and sealed.
실제 사용에 있어서, 상기 단계들에 따라 얻어진 분말 약학 조성물은, 평균 3mm의 두께로, 고품질의 면포로 만들어진 8cm의 직경의 원형 가방형태로서 균일하게 분산되고 고정되며, 분말 약학 조성물은 의학적 치료 및 건강 관리 모자의 형성을 위해 중성 수지 층으로 감싸진 후 머리 꼭대기 부분의 모자 직물과 모자 안감의 중간층에 위치하게 된다.In practical use, the powdered pharmaceutical composition obtained according to the above steps is uniformly dispersed and fixed in the form of an 8 cm diameter circular bag made of high quality cotton cloth with a thickness of 3 mm on average, and the powdered pharmaceutical composition is used for medical treatment and health It is wrapped in a layer of neutral resin to form a care cap and placed in the middle layer of the hat fabric and hat lining at the top of the head.
Claims (7)
사담 3 내지 10 중량부, 봉미초 4 내지 12 중량부, 백정화 4 내지 10 중량부, 적작약 4 내지 10 중량부, 황기 5 내지 10 중량부, 당귀 5 내지 12 중량부, 천마 5 내지 12 중량부 및 석창포 5 내지 10 중량부를 포함하는 약학적 조성물.
A pharmaceutical composition for use in medical treatment or health care caps,
Saddam 3 to 10 parts by weight, Bongmicho 4 to 12 parts by weight, 4 to 10 parts by weight of white crystals, 4 to 10 parts by weight of red tide, 5 to 10 parts by weight of Astragalus, 5 to 12 parts by weight, Angelica 5 to 12 parts by weight, and Pharmaceutical composition comprising 5 to 10 parts by weight of Seokchangpo.
The pharmaceutical composition used for the medical treatment or health care cap according to claim 1, further comprising 1 to 2 parts by weight of borneool.
The pharmaceutical composition for use in the medical treatment or health care cap according to claim 1, wherein the pharmaceutical composition further comprises 10 to 20 parts by weight of salt.
The pharmaceutical composition for use in the medical treatment or health care cap according to claim 1, wherein the pharmaceutical composition further comprises 20 to 25 parts by weight of a magnet.
The pharmaceutical composition used in the medical treatment or health care cap according to claim 3, further comprising 20 to 25 parts by weight of a magnet.
A hat with a pharmaceutical composition according to any one of claims 5 to 5 disposed therein.
b. 사담, 봉미초, 석창포 각각을 일정량 취하고, 체관부와 심재를 제거한 후 물로 씻어내며, 약 3mm의 두께의 작은 조각으로 잘라내고, 하루동안 햇볕에 건조시키고, 수분 ?량이 5% 미만이 될 때까지 60℃의 건조기에서 3시간 동안 건조한 후 꺼내어 상온에서 식히고, 분쇄하며, 40 메쉬의 나일론 체로 거르는 단계;
c. 백정화를 일정량 취하고, 백정화의 1/4 양의 황색 포도주를 백정화에 첨가하며, 균일하게 혼합하고, 커버로 1시간동안 밀봉한 후, 색이 갈색이 되고 수분 함량이 5% 미만이 될 때까지 약한 불의 구리 팬에 볶고, 꺼내어 상온에서 식힌 후 분쇄하며, 40 메쉬 나일론 체로 거르는 단계;
d. 당귀를 일정량 취하고, 당귀의 1/10 양의 황색 포도주를 당귀에 첨가하며, 균일하게 혼합하고, 커버로 1시간 동안 밀봉한 후, 색이 진한 갈색이 되고 수분 함량이 5% 미만이 될 때까지 약한 불의 구리 팬에 볶고, 꺼내어 상온에서 식힌 후 분쇄하며, 40 메쉬 나일론 체로 거르는 단계;
e. 적작약과 염정 각각을 일정량 취하고, 4시간 동안 60℃의 오븐에서 건조한 후, 꺼내어 적작약(염정은 제외)의 수분 함량이 5% 미만이 되도록 상온에서 식힌 다음, 각각 분쇄하고 40 메쉬 나일론 체로 거르는 단계;
f. 일정량의 자석을 계량하고, 평균 직경 0.5mm의 작은 자석 입자로 제조하는 단계;
g. 상기 각 약학적 성분들 적당량을 계량하고 혼합하며, 균등하게 분쇄한 후 밀봉하는 단계;
를 포함하는 의학적 치료 및 건강 관리 모자에 사용되는 약학적 조성물의 제조방법.
a. After taking a certain amount of Astragalus and Chunma, drying and grinding for 2 hours in a dryer at 80 ℃ until the moisture content is less than 5%, and then sieving with a 40 mesh nylon sieve;
b. Take a certain amount of Saddam, Bongmicho and Seokchangpo each, remove the phloem and core material, wash with water, cut into small pieces of about 3mm thick, dry in the sun for one day, until the moisture content is less than 5%. Drying for 3 hours in a dryer at 0 ° C., taken out, cooled to room temperature, pulverized, and filtered with a 40 mesh nylon sieve;
c. Take a certain amount of whitening, add a quarter of yellow wine to whitening, mix evenly, seal with cover for 1 hour, and then weaken until the color becomes brown and the moisture content is below 5%. Roasting in a copper pan of fire, taken out, cooled to room temperature, and then ground and sieved with a 40 mesh nylon sieve;
d. Take a certain amount of Angelica, add 1/10 of the yellow wine of Angelica to Angelica, mix evenly, seal with cover for 1 hour, until dark brown and less than 5% moisture content Roasting in a low heat copper pan, taken out, cooled to room temperature and then pulverized, filtered through a 40 mesh nylon sieve;
e. Taking a predetermined amount of each of the white drop and the salt, dried in an oven at 60 ° C. for 4 hours, and then taken out and cooled at room temperature so that the water content of the white drop (except the salt) is less than 5%, and then crushed and filtered through a 40 mesh nylon sieve;
f. Weighing a certain amount of magnet and preparing the small magnet particles with an average diameter of 0.5 mm;
g. Measuring and mixing an appropriate amount of each of the pharmaceutical ingredients, evenly pulverizing and sealing;
Method of producing a pharmaceutical composition used for medical treatment and health care cap comprising a.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020180070476A KR20190143032A (en) | 2018-06-19 | 2018-06-19 | A Pharmaceutical composition used for medical-treatment and health-care hat |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020180070476A KR20190143032A (en) | 2018-06-19 | 2018-06-19 | A Pharmaceutical composition used for medical-treatment and health-care hat |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20190143032A true KR20190143032A (en) | 2019-12-30 |
Family
ID=69102869
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020180070476A KR20190143032A (en) | 2018-06-19 | 2018-06-19 | A Pharmaceutical composition used for medical-treatment and health-care hat |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20190143032A (en) |
-
2018
- 2018-06-19 KR KR1020180070476A patent/KR20190143032A/en not_active Application Discontinuation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103316130A (en) | Traditional Chinese medicine composition for treating trigeminal neuralgia | |
CN101549104A (en) | Traditional Chinese medicine composition for treating trigeminal neuralgia and preparation method thereof | |
CN110772532A (en) | Traditional Chinese medicine composition, insole and health-preserving shoes | |
CN102091237A (en) | Product for nano magnetic-anion far-infrared functional dress therapy | |
CN103316146A (en) | Traditional Chinese medicinal preparation for anesthesia | |
CN101642511B (en) | Traditional Chinese medicine composition for relieving visual fatigue and treating pseudomyopia and preparation method thereof | |
KR20190140616A (en) | A pharmaceutical composition used for medical-treatment and health-care hat | |
KR20190143032A (en) | A Pharmaceutical composition used for medical-treatment and health-care hat | |
KR20190138327A (en) | A pharmaceutical composition used for medical-treatment and health-care hat | |
KR20190131222A (en) | A pharmaceutical composition used for medical-treatment and health-care hat | |
KR20190133462A (en) | A pharmaceutical composition used for medical-treatment and health-care hat | |
KR20200001752A (en) | A Pharmaceutical Composition Used for Medical-treatment and Health-care Hat | |
JP2020111516A (en) | Pharmaceutical composition used for medical-treatment and health-care hat | |
JP2020019742A (en) | Pharmaceutical compositions used for medical and health care hats | |
DE102018109836A1 (en) | PHARMACEUTICAL COMPOSITION FOR MEDICAL TREATMENT AND HEALTH CAP | |
DE102018109181A1 (en) | Pharmaceutical composition used in a medical care and health care business | |
JP2020111511A (en) | Pharmaceutical compositions used for medical and health care hats | |
CN104225128A (en) | Pharmaceutical preparation for relieving headache caused by cervical spondylosis and preparation method of pharmaceutical preparation | |
CN104013828A (en) | Traditional Chinese medicine composition for treating head wind caused by liver-yang hyperactivity | |
DE102018218591B4 (en) | Pharmaceutical composition used for a hood for medical and health care | |
CN108742009A (en) | Antihypertensive health care medicine-filled pillow | |
CN1088816A (en) | " Huxinxiangtong " powder medicine for treating heart diseases | |
CN103948271B (en) | A kind of Chinese medicine health-care pillow, health pillow and uses thereof | |
CN1100316A (en) | Medicinal composite for medical health cap | |
CN106729276A (en) | A kind of traditional Chinese herbal decoction for treating vertigo |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |